TTRAIL Transferable Trustworthy Radiotherapy with Artificial Intelligence
- Coordinator
- Universite De Rennes, France
- Runs
- 1 March 2027 to 28 February 2031
- Status
- Running
- EU funding
- €4.7m
- Total cost
- —
- Partners
- 24 organisations in 9 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101312626
What the project is doing
In the project's own words, from its summary on CORDIS.
Cancer is the leading cause of death in Europe and the second worldwide. Over 50% of patients are treated with Radiotherapy (RT) and it accounts for 40% of cures, yet recurrence and toxicities remain significant challenges. Despite major advances in imaging, planning and delivery, RT still largely follows a “one-dose-fits-all” approach, leading to variable outcomes, toxicities and limited adaptability to patient-specific biology.
Europe is currently undergoing a digital transformation driven by AI, advanced imaging and the European Health Data Space, but current AI solutions in RT remain fragmented, poorly generalizable and insufficiently explainable, preventing their safe deployment in clinical practice. TTRAIL aims at improving the safety, precision and personalization of radiotherapy (RT) by training 15 Doctoral Candidates as the first generation of Translational AI Radiotherapy Scientists, capable of uniting AI innovation with clinical radiotherapy, medical physics, regulatory science and digital-health translation.
Their training will span multiscale data integration, uncertainty quantification, explainable and causal outcome modelling, digital twins and real-time adaptive dose delivery, aligned with the EU AI Act. The consortium unites top European universities, engineering schools, cancer centers and major industrial partners, providing access to cutting-edge RT platforms, large multicentre datasets and expertise across AI, imaging, oncology, physics and regulatory compliance.
This intersectoral ecosystem ensures robust scientific training, clinical immersion, industrial exposure and strong open-science practices. By delivering a fully integrated, trust-by-design framework for AI-enabled Adaptive Radiotherapy, TTRAIL will produce highly skilled researchers able to lead the future of personalised, safe and explainable cancer treatment in Europe.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universite De Rennes | Rennes | France | Coordinator |
| Universitaet Bern | Bern | Switzerland | Participant |
| Instituto Tecnologico Metropolitano | Medellin | CO | Associatedpartner |
| Brainlab Se | Munchen | Germany | Associatedpartner |
| Karlsruher Institut Fuer Technologie | Karlsruhe | Germany | Participant |
| Panepistimio Patron | Rio Patras | Greece | Participant |
| Empresa De Base Tecnologica Internacional De Canarias, Sociedad Limitada | Las Palmas De Gran Canaria | Spain | Associatedpartner |
| Idcq Hospitales Y Sanidad SL | Madrid | Spain | Associatedpartner |
| Siemens Healthcare SL | Madrid | Spain | Associatedpartner |
| Universidad Carlos Iii De Madrid | Getafe (Madrid) | Spain | Participant |
| Universidad Rey Juan Carlos | Mostoles | Spain | Participant |
| Centre Hospitalier Regional Et Universitaire De Brest | Brest | France | Associatedpartner |
| Centre Eugène Marquis | Rennes | France | Associatedpartner |
| Dassault Systemes | Velizy Villacoublay | France | Associatedpartner |
| Ecole Centrale De Nantes | Nantes Cedex 3 | France | Participant |
| Eurecom Gie | Biot | France | Participant |
| Institut Mines-Telecom | Palaiseau | France | Participant |
| Sorbonne Universite | Paris | France | Associatedpartner |
| Unicancer | Paris | France | Associatedpartner |
| Fondazione Irccs Istituto Nazionale Dei Tumori | Milan | Italy | Participant |
| Ospedale San Raffaele SRL | Milano | Italy | Associatedpartner |
| Politecnico Di Milano | Milano | Italy | Associatedpartner |
| Kiwa Nederland BV | Apeldoorn | Netherlands | Associatedpartner |
| The University of Manchester | Manchester | United Kingdom | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI